Ehlers Danlos syndrome is a group of genetic connective tissue disorders that can affect the skin, joints, blood vessels, and organs throughout the body. Despite being more common than many people think, it often takes years for patients to receive an accurate diagnosis. Understanding the key facts about this condition can empower patients and families to seek the right care sooner.
1. It Is Actually a Group of 13 Different Subtypes
When people hear “Ehlers Danlos syndrome,” they often think of a single condition. In reality, researchers have identified 13 distinct subtypes, each with unique features. According to the NIH, Ehlers Danlos syndrome is a genetic disorder affecting collagen formation that impacts multiple organ systems, with prevalence estimated between 1 in 5,000 and 1 in 100,000 depending on the subtype. Some forms primarily affect the skin and joints, while others can involve life-threatening vascular complications. Knowing which subtype a person has is critical for tailoring the right treatment plan. If you suspect EDS, ask your doctor about genetic testing and subtype classification.
2. The Hypermobile Type Is the Most Common — and Hardest to Diagnose
Hypermobile Ehlers Danlos syndrome, or hEDS, accounts for the vast majority of diagnosed cases. Unlike other subtypes, hEDS currently has no confirmed genetic marker. The NIH notes that hEDS features generalized joint hypermobility, chronic pain, instability, and soft hyperextensible skin, and it is diagnosed clinically rather than through a specific genetic test. This reliance on clinical criteria makes misdiagnosis frustratingly common. Patients are often told their symptoms are psychosomatic before receiving a proper evaluation. Seeking a specialist familiar with connective tissue disorders can make a significant difference in getting an accurate diagnosis.
3. It Affects Far More Than Just the Joints
Many people associate EDS with flexible joints, but the condition reaches far beyond the musculoskeletal system. Collagen is the most abundant protein in the human body, and faulty collagen affects skin, blood vessels, organs, and even the digestive tract. Patients frequently experience gastrointestinal issues, cardiovascular irregularities, and chronic fatigue alongside joint problems. Dental fragility and slow wound healing are also commonly reported. Understanding EDS as a whole-body condition helps patients and providers connect seemingly unrelated symptoms. If you have EDS and notice new symptoms, share them with your care team rather than dismissing them as unrelated.
4. Women Are Diagnosed at Different Rates Than Men
Research suggests a significant gender gap in EDS diagnosis patterns. A large-scale analysis of UK medical records revealed a diagnosed prevalence of 194.2 per 100,000 for EDS and joint hypermobility syndrome, with pronounced gender differences in the age of diagnosis. Women tend to be diagnosed later and experience more widespread symptoms. Hormonal fluctuations may play a role in symptom severity, particularly around menstruation and pregnancy. This disparity means women often endure years of unexplained pain before finding answers. Advocating for thorough evaluation — regardless of gender — remains essential for early and accurate diagnosis.
5. Chronic Pain Is One of the Most Debilitating Symptoms
Joint hypermobility might sound like a party trick, but the chronic pain it causes is anything but entertaining. Unstable joints lead to frequent subluxations and dislocations, creating persistent inflammation and nerve irritation. Many EDS patients describe pain that is widespread, unpredictable, and resistant to standard painkillers. The pain often worsens with activity but can also flare during rest. Over time, this ongoing discomfort can severely limit daily functioning and quality of life. Working with a pain management specialist who understands connective tissue disorders can help patients develop a more effective coping strategy.
6. New Genetic Research Is Shedding Light on Its Causes
Scientists are making exciting progress in understanding the genetic underpinnings of EDS. A recent genome-wide association study identified common genetic variants near the ACKR3 gene and in the SLC39A13/PSMC3 loci that may contribute to hEDS, involving neuroimmune and pain signaling pathways. These findings suggest that EDS involves more than just structural collagen defects. The immune system and nervous system appear to play significant roles as well. This expanding genetic picture may eventually lead to targeted therapies. For now, it validates what patients have long reported — that EDS pain has a complex biological basis.
7. Physical Therapy Is a Cornerstone of Treatment
There is currently no cure for Ehlers Danlos syndrome, but physical therapy is widely considered one of the most effective management strategies. The goal is to strengthen the muscles surrounding unstable joints, providing external support that weakened connective tissue cannot. Studies indicate that low-impact exercises like swimming, Pilates, and targeted strength training can improve stability and reduce pain episodes. However, not all physical therapy approaches are appropriate for EDS patients. Aggressive stretching or high-impact exercises can actually worsen symptoms. Finding a physical therapist experienced with hypermobility disorders is one of the most impactful steps a patient can take.
8. Mental Health Impacts Are Significant and Often Overlooked
Living with a chronic, often invisible illness takes a serious toll on mental health. Research suggests that EDS patients experience higher rates of anxiety, depression, and psychological distress compared to the general population. The constant cycle of pain, medical appointments, and feeling misunderstood can be emotionally exhausting. Many patients also struggle with grief over lost abilities and lifestyle changes. Unfortunately, mental health screening is not always part of standard EDS care. If you or a loved one has EDS, prioritizing mental health support through counseling or peer support groups can be just as important as managing physical symptoms.
9. Diagnosis Often Takes Years of Searching
The average EDS patient sees multiple doctors over many years before receiving a correct diagnosis. Because symptoms overlap with so many other conditions, patients are frequently misdiagnosed with fibromyalgia, anxiety disorders, or even malingering. Many EDS subtypes are unfamiliar to general practitioners, adding another barrier. The lack of a definitive genetic test for hEDS compounds the problem further. Patients often become their own best advocates, researching symptoms and requesting referrals to geneticists or rheumatologists. Keeping a detailed symptom journal can be incredibly helpful when navigating appointments and pushing for appropriate testing.
10. It Commonly Overlaps With Other Conditions
Ehlers Danlos syndrome rarely travels alone. Clinical evidence shows frequent overlap with conditions like postural orthostatic tachycardia syndrome, mast cell activation syndrome, and Chiari malformation. Patients may also experience irritable bowel syndrome, temporomandibular joint dysfunction, and chronic migraines. These comorbidities can make EDS feel overwhelming to manage, but recognizing the connections between them is actually empowering. When doctors understand that these conditions share a common thread, they can create a more cohesive and effective care plan. Ask your provider about screening for related conditions if you already have an EDS diagnosis.
Ehlers Danlos syndrome is a complex, multisystem condition that deserves far greater awareness and understanding. Whether you are newly diagnosed or supporting someone who is, staying informed about the latest research and treatment approaches can make a meaningful difference. Start by connecting with a healthcare provider who specializes in connective tissue disorders and build a care team that sees the full picture.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.
